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Abstract: Tissue injury and inflammation may result in chronic pain, a severe debilitating disease
that is associated with great impairment of quality of life. An increasing body of evidence indicates
that members of the Rab family of small GTPases contribute to pain processing; however, their
specific functions remain poorly understood. Here, we found using immunofluorescence staining
and in situ hybridization that the small GTPase Rab27a is highly expressed in sensory neurons
and in the superficial dorsal horn of the spinal cord of mice. Rab27a mutant mice, which carry a
single-nucleotide missense mutation of Rab27a leading to the expression of a nonfunctional protein,
show reduced mechanical hyperalgesia and spontaneous pain behavior in inflammatory pain models,
while their responses to acute noxious mechanical and thermal stimuli is not affected. Our study
uncovers a previously unrecognized function of Rab27a in the processing of persistent inflammatory
pain in mice.
Keywords: Rab27a; inflammatory pain; spinal cord; dorsal root ganglia; mice
1. Introduction
Chronic pain is a major source of suffering and one of the most frequent causes for patients to
seek medical care [1]. Currently available treatments may be associated with sometimes severe side
effects and are often only partially effective. Thus, it is important to elucidate molecular mechanisms
of nociceptive processing in order to develop novel strategies for chronic pain treatment [2–4].
Accumulating evidence suggests that various Rab proteins contribute to pain signaling, but their
specific functions remain poorly understood. In general, Rab proteins belong to the Ras superfamily
of small guanosine triphosphatases (GTPases). As monomeric G-proteins they exist in a GTP and
a GDP-bound state and their activity is regulated by guanosine nucleotide dissociation inhibitors
and guanine nucleotide exchange factors (for review see [5]). More than 60 Rab proteins have been
identified, which are involved in basic cellular processes such as cellular trafficking, vesicular trafficking
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and synaptic plasticity. In a previous study, we found that Rab7 contributes to the processing of
inflammatory pain in a redox-dependent manner [6]. Moreover, expression of Rab7 is upregulated
after peripheral nerve injury [7] and Rab7-mediated lysosomal targeting of µ-opioid receptors leads
to a loss in opioid antinociception in diabetic neuropathic pain [8]. Furthermore, trafficking of the
neurokinin 1 receptor (NK1R) in sarcoma virus-transformed rat kidney epithelial cells was found to be
controlled by Rab5a [9] and expression of Rab23 was induced in an inflammatory pain model [10],
suggesting that, also, other Rab proteins contribute to the processing of pain.
Another Rab protein that might be involved in pain signaling is Rab27a. Previous studies
demonstrated that Rab27a regulates the motility and exocytosis of lysosome-related organelles and
secretory granules in distinct cells; e.g., melanosomes in melanocytes, lytic granules in cytotoxic T
cells and dense granules in platelets [11]. Mutations in the gene encoding for Rab27a result in the
Griscelli Syndrome Type 2 (GS2), an autosomal recessive pigmentation disorder that is associated
with severe immunological defects, caused by impaired function of neutrophil and natural killer
cells as well as by malfunctioning cytotoxic T-lymphocytes [12–15]. In line with this, Rab27a mutant
mice (Rab27aash/ash) show dysfunction of melanosomes in melanocytes as well as impaired granule
exocytosis of neutrophils [16–19].
Interestingly, some studies also suggest a neural expression of Rab27a. For example, Rab27a was
found to be upregulated in cholinergic basal forebrain neurons in mild cognitive impairment and
Alzheimer’s disease [20] and silencing Rab27a in primary hippocampal neuronal cultures resulted in
attenuated calcium release from intracellular acidic calcium stores probably by attenuated exocytotic
insertion of N-type calcium channels into the plasma membrane [21]. Furthermore, Rab27a has
been shown to be expressed in the cortex and hippocampus where it probably controls exosome
secretion [22]. Other studies provide evidence for a Rab27a expression in Schwann cells, in which it
seems to regulate myelination processes of dorsal root ganglia in vivo [23,24], further supporting the
idea that Rab27a exerts its functions not only in melanocytes and immune cells but also in the nervous
system. However, despite its obvious neuronal expression, only little is known about the functional
role of Rab27a in nociception. In this study we investigated the expression of Rab27a in nociceptive
tissues and characterized its role in pain processing.
2. Materials and Methods
2.1. Animals
Generation of mice bearing a spontaneous single nucleotide mutation of Rab27a (Rab27aash/ash),
designated ashen [19,25], on a C57BL/6J background has been described previously [26].
Rab27aash/ash and wild type mice from heterozygous breeding were used. Genotyping was
performed with gene specific primers (5′-ACCTGACAAATGAGCAAAGTTTCCTCAATG-3′ and
5′-GGAGCAGGGCAGGGCTGGGGAAACCACTCG-3′) followed by enzymatic restriction analysis
with TaqI and RsaI [26]. In addition, tissue expression studies were performed in male C57BL/6N mice
(Jackson Laboratories/Charles River, Sulzfeld, Germany). Animals were housed on a 12/12 h light/dark
cycle with free access to water and food. All experiments were approved by the local Ethics Committee
for Animal Research (Regierungspräsidium Darmstadt, Germany, approval number # V 54 – 19 c 20/15
– FU/1105 (2/2/2016)) and adhered to the guidelines of the Committee for Research and Ethical Issues of
the International Association for the Study of Pain.
2.2. Behavior
Experiments were performed using littermate male and female mice at the age of 2 to 5 months.
Rab27a mutant mice have a lightened, gray coat color because of defects in pigment granule transport,
whereas wild type (WT) control mice have a black coat color. Therefore, various attempts were made to
ensure the blinding of observers in behavioral experiments. Some experiments (formalin test, dynamic
weight bearing) were video-taped and analyzed with increased contrast to prevent recognition of the
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coat color. All other experiments were performed by at least two observers in different experimental
groups to confirm the tendency of the experimental outcome between observers.
Rotarod test. A rotarod treadmill for mice (Ugo Basile, Varese, Italy) was used to assess motor
coordination, running at a constant rotating speed of 12 rpm. After several training sessions, fall-off
latencies from 3 to 5 tests were averaged. The cut-off time was set at 120 s.
Tape response assay. The tape response assay was performed to investigate basal touch sensitization
in Rab27a mutant mice [27]. A common lab tape (3 cm long) was placed gently on the back of the
mouse and the number of responses in 10 min were measured. A bite into the tape, shaking (wet-dog
shake) or scratching the tape was considered as a positive reaction.
Hot plate test. Mice were placed in an acrylic glass cylinder on a heated plate (50, 52, and 54 ◦C)
and the latency time to the first nociceptive reaction (licking of the hind paws, shaking of the hind paws,
jumping on the edge of the plexiglass cage) was measured [28]. Measurement at different temperatures
was performed as the extent of activation of different heat receptors and the processing of thermal
stimuli depend on the intensity of the stimulus [29,30]. In order to avoid tissue damage, cutoff times of
60 s, 40 s, and 20 s, respectively, were chosen.
Dynamic plantar test. Mechanical paw withdrawal latencies were determined with a Dynamic
Plantar-Aesthesiometer (Ugo Basile). The device consists of a stainless steel probe (0.5 mm diameter),
which is pressed against the plantar surface of the paw (sural nerve skin area) by increasing force
through a wire mesh bottom. A clear paw withdrawal was evaluated as a reaction. The force acting on
the paw was increased from 0 to 5 g over a period of 10 s (0.5 g/s ramp) and then remained constant
at 5 g for further 10 s (total switch-off time, 20 s). The latency was calculated as the average of four
consecutive exposures with at least 20 s in between [31–33].
Formalin test. A 0.5% formaldehyde solution (15 µl; formalin) was injected subcutaneously into
the dorsal site of one hind paw [34,35]. The time spent licking the formalin-injected paw was recorded
in 5 min intervals up to 60 min after formalin injection.
Zymosan- and Complete Freund′s Adjuvant (CFA)-induced paw inflammation. Induction of paw
inflammation by zymosan and CFA has been described previously [6,36]. Briefly, 15 µL of a zymosan A
suspension (5 mg/mL in 0.1 M PBS, pH 7.4; Sigma-Aldrich, Steinheim, Germany) or 20 µL of complete
Freund‘s adjuvant (CFA; containing 1 mg/mL heat-killed Mycobacterium tuberculosis in paraffin oil
85% and mannide monooleate 15%; Sigma-Aldrich) was injected into the plantar subcutaneous space
of a hind paw [37]. To assess zymosan-induced mechanical hyperalgesia, the Dynamic plantar test
was used as described above. CFA-induced inflammatory pain behavior was investigated using an
automated dynamic weight bearing (DWB) device (Bioseb, Boulogne, France). The device consists of
an acrylic glass cage (11 cm wide × 11 cm long × 20 cm high) and an instrumented floor to measure
the weight borne in each limb. A camera is installed above the cage to validate the animal positions
during the recording. During a habituation phase of 5 min and a recording phase of 5 min the mice
were able to move freely in the cage. After a training session one day before the experiment, the DWB
assessment was performed in naive mice (baseline) and after CFA injection, daily, for a period of
7 days. Following completion of each test, mice were removed and the test chamber was cleaned with
water. The recorded weight distribution of the ipsilateral and contralateral hind paw was analyzed
by using the DWB software as described [38]. A zone was considered as valid when the following
parameters were detected: ≥0.8 g on one captor with minimum of two adjacent captors recording
≥1.0 g. A time segment was considered as valid if ≥3 stable pictures were detected. In all video
sequences, the positions of the paws were manually validated by an observer. The mean of the weight
over the time was used to calculate the ipsilateral hind paw to contralateral hind paw ratio.
2.3. Immunohistochemistry
Tissue preparation and immunofluorescence staining were performed as described
previously [6,31,36]. Shortly, mice were intracardially perfused with 4% paraformaldehyde in PBS
(pH 7.4) and the lumbar spinal cord (L4–L5) and dorsal root ganglia (DRGs) (L4–L6) were dissected,
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post-fixed, and cryoprotected in 20% sucrose overnight. Tissues were cryostat-sectioned at a thickness
of 14–16 µm and stored at −80 ◦C. For immunofluorescence, sections were permeabilized in PBST
(0.1% Triton-X in PBS), blocked in normal goat or donkey serum and 3% bovine serum albumin (BSA)
in PBS, and incubated with primary antibodies diluted in 3% BSA in PBS over night at 4 ◦C or for
2 h at room temperature. The following antibodies were used: rabbit anti-Rab27a (1:200; Synaptic
Systems, Goettingen, Germany # 168013; immunogen consists of a rat Rab27a fusion protein which
shows 99% homology to murine Rab27a (National Center for Biotechnology Information (NCBI) #
AAG24638.1) but only 71% homology to murine Rab27b (NCBI # AF02885.1)), mouse anti-calcitonin
gene-related peptide (CGRP) (1:200; Sigma-Aldrich # C9487), mouse anti-neurofilament 200 (NF200)
(1:2000; Sigma-Aldrich # N0142) and anti-NeuN (1:1000; Synapic Systems # 266004). Sections were then
washed in PBS and stained with secondary antibodies conjugated with Alexa Fluor 488 (Invitrogen,
Carlsbad, CA, USA), Cy3 (Sigma-Aldrich) or Cy5 (Invitrogen). For staining with Griffonia simplicifolia
isolectin B4 (IB4), sections were incubated with Alexa Fluor 488-conjugated IB4 (10 µg/mL in PBS;
Invitrogen) for 2 h at room temperature. After immunostaining, slides were immersed for 5 min in
0.06% Sudan black B (in 70% ethanol) to reduce lipofuscin-like autofluorescence [39,40], washed in
PBS and coverslipped. Control experiments were performed in which the primary antibody was
omitted. Images were taken using a Nikon Eclipse Ni-U microscope equipped with a monochrome
DS-Qi2 camera (Nikon, Minato, Tokyo, Japan). Final adjustment of contrast and intensity were done
using Adobe Photoshop software. Images taken from Alexa Fluor 488 stainings are presented in green,
whereas images taken from Cy3 or Cy5 stainings are presented in magenta or yellow, respectively.
To analyze DRG neuron subpopulations, the percentage of neurons positive for marker (IB4,
CGRP and NF200) was calculated from 3–4 animals per genotype (>1000 cells per genotype and
marker). Only DRG neurons showing staining clearly above background were included. Sections were
chosen randomly with at least 70 µm apart.
2.4. In Situ Hybridization
Mice were perfused with 4% formaldehyde (PFA) in PBS for 5 min. Lumbar (L4–L5) spinal
cords and DRGs were dissected and post-fixed in the same fixative for 10 min. Tissue was then
incubated in 20% sucrose in PBS at 4 ◦C overnight, embedded in tissue freezing medium (Leica,
Wetzlar, Germany), and cryostat sections were cut at a thickness of 14 µm and stored at −80 ◦C. In situ
hybridization (ISH) was performed using an QuantiGene ViewRNA Tissue Assay (Thermo Fisher
Scientific, Frankfurt, Germany). Experiments were performed according to the instructions of the
manufacturer and included extensive washing steps as described previously [6]. Probes specific for
mouse Rab27a (catalog # VB1-3028872, Thermo Fisher, NCBI # NM_001301230.1) and scramble control
for type 1 (catalog # VF1-17155) were incubated overnight at 40 ◦C (Thermobrite, Leica, Wetzlar,
Germany). Sections were then consecutively incubated with PreAmplifier Mix QT, Amplifier Mix QT,
an alkaline phosphatase labeled probe against the Amplifier, AP Enhancer Solution, and Fast Red
Substrate. Finally, sections were mounted with Fluoromount G (Southern Biotech, Birmingham, AL,
USA) or further processed for subsequent immunohistochemistry.
For in situ hybridization experiments combined with immunohistochemistry, hybridization of
Rab27a was performed as described above. Sections were then blocked in 10% normal goat serum
(NGS) and 3% BSA in PBST for 1 h and incubated with primary antibodies overnight using rabbit
anti-NF200 (1:1000; Sigma-Aldrich # N4142) and mouse anti-peripherin (1:500; Chemicon/Merck
Millipore, Darmstadt, Germany # MAB1527). After rinsing in PBS, slides were incubated with
secondary antibodies conjugated with Alexa Fluor 488 or Cy5 (Life Technologies) for 2 h at room
temperature. Nuclei were stained with DAPI (600 nM; Invitrogen # D1306) and slides were covered
with mounting medium and a coverslip as described above. Images were taken using a Nikon Eclipse
Ni-U microscope as described above. To analyze the distribution of Rab27 mRNA in DRG neurons,
only Rab27-positive profiles with a clear nucleus were analyzed. The percentage of all DRG neurons
(visualized by the autofluorescence of DRG neurons) positive for Rab27 and of Rab27-positive DRG
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neurons expressing peripherin or NF200 was calculated. In total >650 DRG neurons of 4 animals (at
least 100 cells per animal) were counted.
2.5. Western Blot
Lumbar (L4–L5) spinal cords and DRGs were dissected, frozen in liquid nitrogen and stored
at −80 ◦C until use. Samples were homogenized in Phosphosafe buffer (Novagen/Merck Millipore)
combined with a protease inhibitor cocktail (Complete Mini; Roche Diagnostics, Mannheim Germany).
Extracted proteins (30 µg per lane) were separated by SDS-polyacrylamide gel electrophoresis and
blotted onto a nitrocellulose membrane. Membranes were blocked in blocking buffer (Odyssey blocking
buffer, LI-COR Bioscience, Bad Homburg, Germany; diluted 1:1 in PBS) for 1 h at room temperature
(RT) and then incubated with rabbit anti-Rab27a (1:500; Proteintech, Manchester, UK # 17817-1AP;
immunogen consists of a human Rab27a fusion protein, which shows 96% homology to murine Rab27a
(NCBI # AAG24638.1) but only 71% homology to murine Rab27b (NCBI # AF02885.1)) or mouse
anti-GAPDH (1:2000; Ambion # AM4300) dissolved in blocking buffer containing 0.1% Tween-20
overnight at 4 ◦C. After incubation with secondary antibodies for 1 h at RT, proteins were detected
using an Odyssey Infrared Imaging System (LI-COR Bioscience). Quantification of band densities was
done using Image Studio Lite software (LI-COR).
2.6. Real-Time RT-PCR
Total RNA of lumbar DRGs (L4-L5) and the lumbar spinal cord (L3-L5) was extracted under
RNase-free conditions using a RNAqueous Micro Kit (Ambion/Life Technologies, Carlsbad, CA,
USA) or a RNeasy Mini Lipid Tissue Kit (Qiagen, Hilden, Germany), respectively. Genomic DNA
contaminations were reduced by treating samples with DNase for 15 min. Reverse transcription
was performed using a Verso Kit (Thermo Fisher Scientific, Frankfurt, Germany) according to the
manufacturer’s instructions. Quantitative real-time RT-PCR (qPCR) was performed with an ABI Prism
7500 Sequence Detection System (Applied Biosystems/Life Technologies) using SYBR green (Applied
Biosystems/Life Technologies) and gene specific primers for murine Rab27a (Fwd 5′- TTC AGG GAC
GCT ATG GGT TT-3′ and Rev 5′- CCA CAC AGC ACT ATA TCT GGG-3′, NCBI # AB120511.1,
nucleotides 265–395), Rab27b (Fwd 5’-TGG TCT CAA TGT CTG TGC CA-3’ and Rev 5’-AGC TCA
CGA CAT TCA CCA GA-3’, NCBI # NM_030554.4, nucleotides 3017–3139) and GAPDH (Fwd 5’-CAA
TGT GTC CGT CGT GGA TCT -3’ and Rev 5’-GTC CTC AGT GTA GCC CAA GAT G-3’, NCBI #
XM_017321385.2, nucleotides 1145–1352). RT-PCR products generated by Rab27a or Rab27b primer
pairs result in in specific products for Rab27a or Rab27b, respectively. Reactions were performed in
duplicate or triplicate by incubating for 10 min at 95 ◦C, followed by 40 cycles of 15 s at 95 ◦C and
1 min at 60 ◦C, including water controls to ensure specificity. Relative gene expression levels were
calculated using the comparative 2-∆∆Ct method and normalized to GAPDH.
2.7. Statistics
Statistical analysis was performed with SPSS software using the Student’s t test for paired
comparisons, or one-way ANOVA for multiple comparisons followed by a Fisher post hoc test. When
mice were tested at different time points we used a repeated-measures two-way ANOVA and differences
between groups at each time point were analyzed with a Fisher’s least significant difference (LSD)
post-hoc test. Rotarod fall-off latencies were analyzed with Mann-Whitney U test and are expressed as
median and interquartile range. All other data are presented as the mean ± standard error of the mean
(SEM). For all tests, a probability value p < 0.05 was considered as statistically significant.
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3. Results
3.1. Rab27a Expression in the Spinal Cord and in Dorsal Root Ganglia
We first investigated the expression of Rab27a in the spinal cord and DRGs of naive wildtype
(WT) mice using an antibody whose specificity was previously demonstrated [41]. In Western blot
experiments we detected Rab27a in both the spinal cord and DRGs at the expected size around












cord  compared  to DRGs  (n  =  4),  *p  <  0.001. Some  additional bands  around  40–50 kDa were  also 
detected, which seem to be unspecific. 
Interestingly,  immunostaining experiments  in  the spinal cord of naive mice  revealed Rab27a 




the  cellular  distribution  of  Rab27a  in  the  spinal  cord  using  double‐labeling  immunostaining 
experiments. We observed that Rab27a partly co‐localizes with CGRP and isolectin B4 (IB4), which 
are  established markers  for  nociceptive  peptidergic  and  non‐peptidergic  C  fibers,  respectively, 
terminating in the superficial dorsal horn (Figure 2B and C). By contrast, Rab27a is not colocalized 
with NF200, a marker for myelinated primary afferent fibers (Figure 2D). In the ventral horn, Rab27a 
immunoreactivity was  found  in cells expressing NeuN, a marker of neuronal somata  (Figure 2E). 
Figure 1. Western blot of Rab27a in the spinal cord and dorsal root ganglia (DRGs) of naive wild type
(WT) mice. Rab27a expression at the expected size of 25–27 kDa is significantly stronger in the spinal
cord compared to DRGs (n = 4), * p < 0.001. Some additional bands around 40–50 kDa were also
detected, which seem to be unspecific.
Interestingly, immunostaining experiments in the spinal cord of naive mice revealed Rab27a
immunoreactivity to be enriched in the superficial dorsal horn (Figure 2A), i.e., in an area that is
important for nociceptive signaling. Rab27a immunoreactivity was also detected to a lesser extent in a
scattered pattern in the ventral horn (Figure 2A). As expected, no immunofluorescence was detected in
control experiments omitting the primary anti-Rab27a antibody (Figure 2A’). We then analyzed the
cellular distribution of Rab27a in the spinal cord using double-labeling immunostaining experiments.
We observed that Rab27a partly co-localizes with CGRP and isolectin B4 (IB4), which are established
markers for nociceptive peptidergic and non-peptidergic C fibers, respectively, terminating in the
superficial dorsal horn (Figure 2B,C). By contrast, Rab27a is not colocalized with NF200, a marker for
myelinated primary afferent fibers (Figure 2D). In the ventral horn, Rab27a immunoreactivity was
found in cells expressing NeuN, a marker of neuronal somata (Figure 2E). Together, the enriched
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Figure 2. Rab27a localization in the spinal cord. (A) Immunostaining experiments detected Rab27a in
the dorsal horn and in some ventral horn neurons. No specific signal was detected by omitting the
primary antibody (A’, negative control). (B–D”) Double immunolabeling experiments with established
markers revealed that Rab27a colocalizes with calcitonin gene-related peptide (CGRP) (B–B”) and
isolectin B4 (IB4) (C–C”), while there was virtually no co-expression with neurofilament 200 (NF200)
(D–D”). (E–E”) Rab27a protein also co-localizes with NeuN, a neuronal marker, in the ventral horn of
the spinal cord. Scale bars A: 100 µm, (B–D): 50 µm, E: 10 µm.
In DRGs we were not abl to detect a specific Rab27a immunofluorescence signal using various
staining protocols. We therefore investigated the distribution of Rab27a mRNA using fluorescent in
situ hybridization (ISH). Hybridization signals for Rab27a RNA were detect d in many DRG cells
in close ximity of DAPI-positive nuclei. Of note, the signal appeared to be localized in distinct
compartments within the cells (Figure 3A). No hybridization signals were detected usi g a scramble
control probe (Figure 3B). ISH combi ed with immunostaini g revealed that 63.03% ± 10.68% of cells
positive for peripherin, a marker for C-fiber neurons, also expressed Rab27a (Figure 3C–F). Moreover,
36.97% ± 10.68% of cells expressing NF200, a marker for myelinat d prim ry afferent neurons, were
iti e for Rab27a. In total Rab27a mRNA was expressed in 70.70% ± 2.27% of sensory neurons.
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As some Rab27a hybridization signals were found in close proximity of DAPI-positive nuclei which did
not co-localize with the neuronal markers, our staining further suggests that Rab27a is also expressed in
non-neuronal DRG cells. Altogether, these data show an enriched expression of Rab27a in nociceptive
C fiber neurons, suggesting a possible contribution to pain processing.
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and  Rab27aash/ash mice  (Figure  4B).  Further,  the  distribution  of  IB4‐binding  and  CGRP‐positive 
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Figure 3. Localization of Rab27a mRNA in dorsal root ganglia. (A) Fluorescent in situ hybridization
detected Rab27a mRNA in DRG neurons and non-neuronal cells. (B) No hybridization signal was
detected using scramble (negative) control. (C–F) In DRG neurons Rab27a mRNA colocalizes with
peripherin-positive and NF200-positive DRG neurons. Scale bars: A and C = 25 µm.
3.2. Rab27aash/ash Mice Display Normal Basal Sensitivity
To investigate a possible function of Rab27a in pain processing, we characterized the behavior of
Rab27aash/ash and littermate WT mice in animal models of pain. Rab27aash/ash mice are viable, fertile
und do not show any gross behavioral impairments. However, due to defects in pigment granule
transport they exhibit a gray coat color (Figure 4A). In order to obtain reliable results, special attention
was paid to blinding in the behavior experiments (see material and methods).
For basal characterization of nociceptive pathways, we analyzed the percentage of DRG neuron
populations positive for the marker NF200, IB4, and CGRP and observed no differences between
WT and Rab27aash/ash mice (Figure 4B). Further, the distribution of IB4-binding and CGRP-positive
terminals in the superficial dorsal horn is similar between genotypes (Figure 4C), suggesting that there
are no gross developmental defects affecting DRG neuron subpopulations and spinal cord morphology
in Rab27aash/ash mice. The expression of Rab27b, the second Rab27 isoform, is not compensatory
regulated in DRGs and the spinal cord of Rab27aash/ash mice (Figure 4D,E). Moreover, as a prerequisite
for interpretation of behavioral pain studies, the motor function was not impaired in Rab27aash/ash
mice as assessed by the rotarod test (mice of both genotypes reached a median fall off latency of 120 s).
We then investigated basal sensitivity to mechanical stimuli in Rab27aash/ash mice using the
Dynamic plantar test (Figure 5A) and the tape response test (Figure 5B) and found that the responses
were not affected by the Rab27a mutation. Acute responses to noxious thermal stimuli were investigated
using the hot plate test (50, 52, and 54 ◦C; Figure 5C). When the plate was set at a temperature of 52 ◦C,
Rab27aash/ash mice showed slightly, but significantly, prolonged latencies as compared to WT mice.
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By contrast, at a temperature of 50 and 54 ◦C, the nocifensive responses were comparable between
genotypes. Although there was only a weak effect, these data imply that Rab27a is involved in the
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In  order  to  investigate  if  Rab27a  is  involved  in  rapid  sensitization  of  pain  pathways, we 
performed the formalin test. Injection of 0.5% formalin into a hind paw resulted in the typical biphasic 
nociceptive  response  consisting  of  licking  the  injected  paw.  However,  the  licking  behavior  of 
Rab27aash/ash and WT mice was  similar  in  both  phases  (Figure  5D  and E). Altogether,  these data 
suggest that Rab27a plays only a minor role in acute nociceptive processing. 
Figure 4. Basal characterization of Rab27aash/ash mice. (A) Rab27aash/ash mice exhibit a gray coat
color. (B) Quantification of DRG neuron populations in Rab27aash/ash and WT mice. The percentage
of NF200, isolectin-B4 (IB4) and CGRP-positive DRG neurons is similar between genotypes (n = 3).
(C) Distribution of primary afferent terminals as assessed by the markers CGRP and isolectin-B4 (IB4)
is comparable between genotypes; Scale bar: 100 µm. (D–E) The isoform Rab27b is not compensatory
upregulated in Rab27a mutant mice in the spinal cord (D) or in DRGs (E); * p < 0.05.
In order to investigate if Rab27a is involved in rapid sensitization of pain pathways, we performed
the formalin test. Injection of 0.5% formalin nto a hind p w resulted in the typical biphasic nociceptive
response onsis ing of licking the injected paw. However, he licking behavior of Rab27 ash/ash and WT
mice was similar in both phases (Figure 5D,E). Altoge he , these data suggest that Rab27a plays only a
minor role in acute nociceptive proc sing.
3.3. Rab27aash/ash Mice Display Reduced Inflammatory Pain Behavior
We next investigated the behavior of Rab27aash/ash mice in models of persistent inflammatory
pain. In the model of zymosan-induced paw inflammation, the injection of a zymosan A suspension
into a hind paw induced a local inflammatory reaction accompanied by mechanical sensitization of
the paw (Figure 6A). The mechanical hypersensitivity developed similarly over the first 4 h in both
genotypes. Interestingly, however, at later stages the mechanical hypersensitivity was significantly
reduced in Rab27aash/ash mice as compared to WT littermates (Figure 6A), suggesting that Rab27a is
involved in pain processing in response to inflammatory stimuli. We also performed western blot
analyses to investigate expression of Rab27a in the spinal cord of WT mice 4, 8 and 24 h after zymosan
injection into a hind paw. Interestingly, Rab27a expression was significantly upregulated 4 and 8 h
after zymosan injection (Figure 6B), further supporting the hypothesis that Rab27a plays a role in
inflammatory pain.
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test.  The  involvement  of  Rab27a  in  inflammatory  pain  processing  is  further  supported  by  its 
Figure 6. Rab27aash/ash mice show reduced pain behavior in inflammatory pain models. (A) Mechanical
hypersensitivity af er zymosan injection i to a hin i significantly r uced in Rab27aash/ash mice
compared to WT littermates (n = 5). (B) Western blot analyses revealed that Rab27a protein expression
in the spinal is significantly upregulated 4 and 8 h after zymosan injection into a hind paw of WT
mice (n = 6). (C) Rab27aash/ash mice show reduced pain behavior in the Complete Freund′s Adjuvant
(CFA)-model of inflammatory pain as assessed by the dynamic weight bearing (n = 6); * p < 0.05.
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We then assessed the behavior of Rab27aash/ash mice in a second model of inflammatory pain.
For that purpose, paw inflammation was induced by injection of CFA into a hind paw. In this model
we quantified the extent of inflammatory pain using the dynamic weight bearing test, which enables
assessment of spontaneous pain in freely moving animals and may thus allow for a clinically more
relevant readout of pain as compared to reflexive pain tests [38]. As shown in Figure 6C, the CFA
injection resulted in decreased weight bearing of the ipsilateral paw in both genotypes. However,
at later time points Rab27aash/ash mice showed significantly reduced spontaneous pain behavior
compared to their WT littermates. Together, these data imply that Rab27a is involved the processing of
inflammatory pain.
4. Discussion
We here describe a previously unknown function of the small GTPase Rab27a in pain processing.
Rab27a is highly expressed in nociceptive C fiber neurons and their terminals in the superficial dorsal
horn of the spinal cord. Rab27a mutant mice showed normal responses to acute nociceptive stimuli,
but their behavior in inflammatory pain models was significantly reduced. These data suggest that
Rab27a plays a pronociceptive role in inflammatory pain models.
The enriched expression of Rab27a in sensory neurons is supported by a recent single cell RNA
sequencing study [42]. As we demonstrate that (i) Rab27a protein is expressed to a much higher extend
in the spinal cord as compared to DRG neurons, (ii) Rab27a can only be detected on mRNA but not
on protein level in DRGs and (iii) Rab27a protein signal is enriched in the superficial dorsal horn of
the spinal cord, co-localizing with marker for primary afferent neurons, our data suggest that Rab27a
protein in sensory neurons might be transported to central terminals within the spinal cord. As Rab27a
is an important regulator of exocytosis processes in various cell types [43–48], it seems likely that also
in the spinal cord Rab27a regulates vesicle transport or vesicle fusion in synaptic terminals of primary
afferent neurons.
We show that Rab27a mutant mice displayed reduced responses in inflammatory pain models
induced by paw injection of zymosan or CFA, as well as slightly reduced responses in the hot
plate test. The involvement of Rab27a in inflammatory pain processing is further supported by its
upregulated expression in the spinal cord after intraplantar zymosan injection, because chronic pain
is accompanied by altered expression of many genes which are required for the biochemical and
structural reorganization of nociceptive circuits [49]. It should be noted, however, that mutations
in the gene encoding for Rab27a are possibly associated with immune defects (for review see [45]).
Rab27a shows strong expression in melanocytes and lymphocytes, in which it regulates exocytosis of
vesicles [13]. Thus, it plays an important role in various steps in the immune defense system such
as exocytosis of azurophilic granules, gelatinase, and specific granules in neutrophils as well as in
the activation of NADPH oxidase 2 in phagocytes [43]. In line with that, defects of Rab27a cause
Griscelli Syndrome type 2 (GS2), an autosomal recessive pigmentation disorder that involves severe
immunological defects [13]. In our study we found Rab27a to be expressed in neuronal cells pointing
to a functional role in pain processing. However, as our data also suggest, a non-neuronal expression
in DRGs and as Rab27a expression is well described in immune competent cells, we cannot exclude the
possibility that impaired immune responses contribute to the reduced inflammatory pain in Rab27a
mutant mice. However, as nociceptive behavior in the hot plate test at 52 ◦C was reduced in Rab27a
mutant mice, this points to a potential contribution of neuronally expressed Rab27a to pain processing.
About the mechanism by which Rab27a contributes to thermal pain and about the reason why
the hot plate behavior of Rab27aash/ash mice was altered at 52 ◦C, but not at 50 or 54 ◦C, we can
only speculate. In general, noxious heat sensing depends on a variety of transient receptor potential
(TRP) ion channels which are expressed in different subpopulations of sensory neurons and alter
their open probability in distinct temperature ranges. One well-characterized TRP channel implicated
in thermal pain is TRPV1, which however only partially contributes to the nocifensive behavior in
the hot plate test [50,51]. A recent study provided evidence that the combined activation of TRPV1,
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TRPM3 and TRPA1 plays a major role in noxious heat detection in mice [52]. However, several other
ion channels have been described as molecular sensors for noxious heat including the TRP channels
TRPV2, TRPV3, TRPV4, and TRPM3, as well as channels of the anoctamin (ANO)/transmembrane
protein 16 (TMEM16) family [53–58], and these channels seem to contribute to the pain behavior at
distinct temperatures. Hence, the altered 52 ◦C hot plate behavior of Rab27aash/ash mice points to
a modulation of the activity of one or more of these channels by Rab27a. Of note, recent studies
reported that Rab27a may modulate the activity of various channels such as the epithelial sodium
channel [59], the cystic fibrosis transmembrane conductance regulator [60] or CaV1.3 channels in
the retinal pigment epithelium [61]. Thus, it seems possible that Rab27a interacts with heat-sensing
channels in sensory neurons.
Despite its expression in various cells, mutations of Rab27a seem to affect mainly functions
of melanocytes and cytotoxic T-lymphocytes. One explanation might be a compensatory effect of
Rab27b, the second Rab27 isoform which is found in vertebrates. Rab27a and Rab27b show 71%
identity in their amino acid sequence and share similar effector domains and carboxy-terminal
isoprenylation motifs; however, they share little sequence identity after the GTP-binding domain
IV [62]. Interestingly, Rab27a and Rab27b are co-expressed in various secretory cells except melanocytes
and cytotoxic-T-lymphocytes [26,63]. Thus, they were originally thought to function in a redundant
manner. However, later studies revealed that the functions of Rab27a and Rab27b differ from each
other as these isoforms interact with different effectors [26,44,64–67]. In this study we found the
isoform Rab27b also to be expressed in the spinal cord and in DRGs, in line with previous studies [42].
However, we detected no compensatory regulation of Rab27b in Rab27aash/ash mice. Despite the fact
that Rab27a mutant mice show reduced heat pain and inflammatory pain behavior, we cannot exclude
the possibility that Rab27b at least partly rescues Rab27a functions in Rab27aash/ash mice.
Altogether, our data suggest that Rab27a is involved in nociceptive processing. The insights
reported here can help us to better understand pain and stimulate further studies to elucidate the
functions of Rab proteins in this context.
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